當前的血管藥理學 SCIE

期刊簡介預計審稿時間： 較慢,6-12周

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

《當代血管藥理學》發表臨床和研究綜述/小綜述、原創研究文章、信件、辯論、藥物臨床試驗研究和特邀編輯的問題，以更新所有關注血管疾病治療的人，彌合臨床實踐與正在進行的研究之間的差距。

血管疾病是西方國家最常見的死亡原因，其發病率在發展中國家呈上升趨勢。因此，大量研究旨在建立有效的急性血管事件治療方法。長期治療也受到了廣泛關注（例如用于緩解癥狀）。此外，有效的預防，無論是初級還是次級的，都得到了幾項具有里程碑意義的試驗結果的支持。血管疾病是一個復雜的領域，涉及初級保健醫生和執業護士以及幾個專業。后者包括心臟病學、血管和心胸外科、普通醫學、放射學、臨床藥理學和神經病學（卒中科）。

《Current Vascular Pharmacology》(當前的血管藥理學)編輯部通訊方式為BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR。如果您需要協助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節省您的寶貴時間，有效提升發表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。